Literature DB >> 12041740

Catalytic DNA: a novel tool for gene suppression.

M J Cairns1, E G Saravolac, L Q Sun.   

Abstract

RNA, as an intermediate in the production of every gene encoded protein and the genetic material of many pathogenic viruses, presents an attractive target for both biological and therapeutic manipulation. Despite its extensive involvement in living systems, its chemical diversity based on four units is relatively low compared with protein. This provides the opportunity for a generic approach to targeting with specificity based on primary structure rather than complex higher order structures. This form of recognition occurs naturally in complementary nucleic acids, due to an ability to bind their single stranded target through Watson-Crick interactions. The most established nucleic acid based approach to gene suppression at the RNA level is through antisense oligodeoxynucleotides (ODNs). These compounds form heteroduplex with target RNA which are thought to either block its function or mediate its destruction by activation of RNase H. Alternatively, RNA can be targeted by catalytic RNA such as the hammerhead ribozyme. Ribozymes have the advantage of being equipped with their own RNA cleavage apparatus and are therefore independent of host nuclear protein activity. At present, the utility of ribozyme oligonucleotides is restricted by the relative difficulty synthesising active molecules with sufficient resistance to nuclease degradation. Recently the power of in vitro selection has been used to evolve catalytic DNA sequences with RNA cleavage specificity and activity rivalling the very best ribozymes, while maintaining the more robust chemistry of an ODN. These deoxyribozymes or DNAzymes have tremendous potential as gene suppression agents for both target validation and therapeutic applications. A number of studies evaluating the biological activity of these compounds have shown promising results. However, as with other oligonucleotide based strategies, future exploitation of this approach may depend on accessory technology to assist with the accessibility of a target which is folded by its own secondary structure and hidden within the intracellular compartment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12041740     DOI: 10.2174/1389450023347722

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  12 in total

1.  Zn2+-dependent deoxyribozymes that form natural and unnatural RNA linkages.

Authors:  Kelly A Hoadley; Whitney E Purtha; Amanda C Wolf; Amber Flynn-Charlebois; Scott K Silverman
Journal:  Biochemistry       Date:  2005-06-28       Impact factor: 3.162

2.  Photochemical DNA activation.

Authors:  Hrvoje Lusic; Douglas D Young; Mark O Lively; Alexander Deiters
Journal:  Org Lett       Date:  2007-04-21       Impact factor: 6.005

Review 3.  DNAzymes and cardiovascular disease.

Authors:  V L Benson; L M Khachigian; H C Lowe
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

4.  A continuous kinetic assay for RNA-cleaving deoxyribozymes, exploiting ethidium bromide as an extrinsic fluorescent probe.

Authors:  Davide Ferrari; Alessio Peracchi
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

5.  Potent Intracellular Knock-Down of Influenza A Virus M2 Gene Transcript by DNAzymes Considerably Reduces Viral Replication in Host Cells.

Authors:  Binod Kumar; Roopali Rajput; Dibya Ranjan Pati; Madhu Khanna
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

6.  Kinetic and thermodynamic characterization of the RNA-cleaving 8-17 deoxyribozyme.

Authors:  Maria Bonaccio; Alfredo Credali; Alessio Peracchi
Journal:  Nucleic Acids Res       Date:  2004-02-12       Impact factor: 16.971

7.  Polyamine derivatives as selective RNaseA mimics.

Authors:  Sandra Fouace; Cyril Gaudin; Sylvie Picard; Sophie Corvaisier; Jacques Renault; Bertrand Carboni; Brice Felden
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

8.  Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.

Authors:  Richard Tritz; Cellia Habita; Joan M Robbins; German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2005

Review 9.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.

Authors:  Scott K Silverman
Journal:  Nucleic Acids Res       Date:  2005-11-11       Impact factor: 16.971

10.  Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif.

Authors:  Amber Goodchild; Andrew King; Mary Margaret Gozar; Toby Passioura; Carly Tucker; Laurent Rivory
Journal:  Nucleic Acids Res       Date:  2007-06-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.